Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
First Claim
1. An antisense oligonucleotide which is complementary to an NTP mRNA sequence, wherein said antisense oligonucleotide is selected from the group consisting of SEQ ID NO:
- 9, SEQ ID NO;
10 and SEQ ID NO;
11.
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are transgenic animals and transfected cell lines expressing a protein associated with Alzheimer'"'"'s Disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas. Also disclosed is the use of such transgenic animals and transfected cell lines to screen potential drug candidates for treating or preventing Alzheimer'"'"'s disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas. The invention also relates to new antisense oligonucleotides, ribozymes, triplex forming DNA and external guide sequences that can be used to treat or prevent Alzheimer'"'"'s disease, neuroectodermal tumors, malignant astrocytomas, and glioblastomas.
-
Citations
12 Claims
-
1. An antisense oligonucleotide which is complementary to an NTP mRNA sequence, wherein said antisense oligonucleotide is selected from the group consisting of SEQ ID NO:
- 9, SEQ ID NO;
10 and SEQ ID NO;
11. - View Dependent Claims (2, 3, 4, 5)
- 9, SEQ ID NO;
-
6. A ribonucleotide external guide nucleic acid molecule comprising a 10-mer nucleotide sequence fused to a 3′
- NCCA nucleotide sequence, wherein N is a purine, wherein said ribonucleotide external guide nucleic acid molecule is selected from the group consisting of SEQ ID NO;
12, SEQ ID NO;
13 and SEQ ID NO;
14. - View Dependent Claims (7)
- NCCA nucleotide sequence, wherein N is a purine, wherein said ribonucleotide external guide nucleic acid molecule is selected from the group consisting of SEQ ID NO;
-
8. An antisense oligonucleotide, which is a 15 to 40 mer and is complementary to an NTP mRNA sequence corresponding to a region within nucleotides 150–
- 1139 of SEQ ID NO;
1, wherein said region includes one or more nucleotides selected from the group consisting of nucleotides 150, 194–
195, 240–
241, 243, 244, 255–
256, 266–
267, 269–
271, 276, 279–
280, 293–
295, 338–
340, 411, 459, 532–
533, 591, 633–
644, 795–
797, 828, 853–
854, 876–
877, 883, 884–
885, 898, 976, 979–
980, 999, 1037, 1043–
1044, 1092–
1096, 1099, and 1116–
1119 of SEQ ID NO;
1. - View Dependent Claims (9, 10, 11, 12)
- 1139 of SEQ ID NO;
Specification